How Top White House Adviser Anita Dunn Is Dodging Ethics Disclosure
The senior Biden strategist has worked with a host of corporate clients at the influential firm SKDK, but a loophole is keeping possible conflicts of interest out of the public eye.
Lee Fang
Lee Fang is a journalist with a longstanding interest in how public policy is influenced by organized interest groups and money. He was the first to uncover and detail the role of the billionaire Koch brothers in financing the tea party movement. His interviews and research on the Koch brothers have been featured on HBO's "The Newsroom," the documentaries "Merchants of Doubt" and "Citizen Koch," as well as in multiple media outlets. He was an investigative blogger for ThinkProgress from 2009 to 2011, and then a fellow at the Investigative Fund of the Nation Institute and contributing writer for The Nation.
In 2012, he co-founded RepublicReport.org, a blog to cover political corruption that syndicates content with TheNation.com, Salon, National Memo, BillMoyers.com, TruthOut, and other media outlets. His work has been published by VICE, The Baffler, the Boston Globe, the San Francisco Chronicle, The Progressive, NPR, In These Times, and the Huffington Post. His first book, "The Machine: A Field Guide to the Resurgent Right," published by the New Press, explores how the conservative right rebuilt the Republican Party and its political clout in the aftermath of Barack Obama's 2008 election victory. He is based in San Francisco.
In 2012, he co-founded RepublicReport.org, a blog to cover political corruption that syndicates content with TheNation.com, Salon, National Memo, BillMoyers.com, TruthOut, and other media outlets. His work has been published by VICE, The Baffler, the Boston Globe, the San Francisco Chronicle, The Progressive, NPR, In These Times, and the Huffington Post. His first book, "The Machine: A Field Guide to the Resurgent Right," published by the New Press, explores how the conservative right rebuilt the Republican Party and its political clout in the aftermath of Barack Obama's 2008 election victory. He is based in San Francisco.
Contacts:
Posts:
The Coronavirus Crisis
Factory Owners Around the World Stand Ready to Manufacture Covid-19 Vaccines
Bill Gates said he doesn’t think the recipe for the vaccine should be shared. Drugmakers are eager to retrofit their facilities and get to work.
The Coronavirus Crisis
Sen. Joe Manchin Supports IP Waiver to Allow Generic Covid-19 Vaccines
The West Virginia lawmaker, a key moderate on Capitol Hill, backs the effort to temporarily suspend IP rights on coronavirus vaccines.
The Coronavirus Crisis
Hollywood Lobbyists Intervene Against Proposal to Share Vaccine Technology
Industries that rely on copyright enforcement want to limit the scope of the World Trade Organization waiver.
The Coronavirus Crisis
Pharmaceutical Industry Dispatches Army of Lobbyists to Block Generic Covid-19 Vaccines
New lobbying disclosures show over 100 drug lobbyists working to defeat the IP waiver request at the WTO.
CVS Health Quietly Made Massive Donation to Dark-Money Group Fighting Access to Care
The pharmacy and health insurance giant gave $5 million to Partnership for America’s Health Care Future.
The Coronavirus Crisis
Howard Dean Pushes Biden to Oppose Generic Covid-19 Vaccines for Developing Countries
The former progressive champion, who now works on behalf of corporate interests, joins the drug industry in arguing against sharing the intellectual property for low-cost vaccines.
The Coronavirus Crisis
Last-Minute Trump Rule Would Let Vaccine Makers Hike Prices Unchecked
The Biden administration could halt an attack on one of the government’s few options to rein in drug prices.
The Coronavirus Crisis
Biden’s Inner Circle Maintains Close Ties to Vaccine Makers, Disclosures Reveal
As concerns grow about a global “vaccine apartheid,” watchdogs worry that the Biden administration is primed to favor profits over people.
The Coronavirus Crisis
Drugmakers Promise Investors They'll Soon Hike Covid-19 Vaccine Prices
Pfizer, Moderna, and Johnson & Johnson pledged affordable vaccines — but only as long as there’s a “pandemic.”